Harbin Medisan Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Harbin Medisan Pharmaceutical Co., Ltd. is publicly traded on SHZ under the ticker 002900.SZ.
Established in 1996 and based in Harbin, China, Harbin Medisan Pharmaceutical Co., Ltd. specializes in the full lifecycle of chemical pharmaceutical products within China, from research and development to manufacturing and sales. The company's comprehensive product line includes both active pharmaceutical ingredients (APIs) and various finished drug forms. Its offerings address a wide array of medical conditions,...
Can you invest in Harbin Medisan Pharmaceutical Co., Ltd.?
Yes. Harbin Medisan Pharmaceutical Co., Ltd. is publicly traded on SHZ under the ticker 002900.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Harbin Medisan Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.